Search Results
Mar 18, 2026, 08:03 ET Omada Appoints Jakob H. Kraglund as CEO to Accelerate Global Growth
challenges, and we are investing heavily in innovation to extend our platform into the next generation of agentic and non-human identity governance. I look forward to working with the Omada team and our partners to deliver the next generation of IGA for AI to enterprises globally."With the updated leadership,
More news about: Omada
Mar 18, 2026, 08:02 ET Innovation Leader Duncan Wardle and Entrepreneur Seb Terry to Speak at Duck Creek Formation '26: Agents of Innovation
Creek's annual user conference designed to convene insurance and technology leaders to exchange insights, accelerate innovation, and shape the industry's next chapter. The event will take place at the Signia by Hilton Bonnet Creek Resort in Orlando, Florida, and bring together more than 800 carriers, partners
More news about: Duck Creek Technologies, Inc.
Mar 18, 2026, 08:00 ET Harmonic Enhances XOS Advanced Media Processor to Streamline Next-Generation Broadcast Distribution
"Broadcasters around the world are navigating major transformations, from spectrum reallocations to migrations to next-generation television standards like ATSC 3.0 and DTV+," said Stéphane Cloirec, vice president, video appliances and software product management, video
More news about: Harmonic Inc.
Mar 18, 2026, 08:00 ET Lumeris Launches Ask Tom to Deliver Agentic Analytics for Primary Care
continuously review enterprise data, detect anomalies or emerging trends and surface opportunities for improvement. In the same way Tom informs best-next actions at the point of care, Ask Tom orchestrates the discovery of clinical and business insights across populations and health system operations.The
More news about: Lumeris
Mar 18, 2026, 08:00 ET Versaterm Appoints Andrew Lazarus as Chief Financial Officer
"We are thrilled to welcome Andrew as our new Chief Financial Officer," said Steve Seoane, CEO of Versaterm. "As we scale towards our next phase of growth, having a world-class financial leader that brings expertise in driving operational rigor and optimizing our go-to-market efficiency
More news about: Versaterm
Mar 18, 2026, 08:00 ET Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine Program
exclusive global license to Valneva's antigen technology targeting Clostridioides difficile. Building on this technology, Elaris plans to advance a next-generation vaccine program incorporating additional proprietary components designed to broaden protective immune responses. The agreement strengthens
More news about: Elaris
Mar 18, 2026, 08:00 ET IQST - IQSTEL Releases Shareholder Letter Highlighting Strategic Expansion, AI Platform Development and Global Investor Outreach
goal has been to create a scalable platform capable of supporting the next generation of communications, automation, and digital services.With that foundation now in place, we believe IQSTEL is positioned to enter the next stage of its evolution.Our strategy moving forward is centered on
More news about: iQSTEL
Mar 18, 2026, 08:00 ET SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support
mid- to long-term growth foundation through a diversified infectious disease pipeline, including next-generation pneumococcal vaccines, universal coronavirus vaccines, avian influenza vaccines, and mRNA and next-generation vaccine platforms. The company aims to secure global competitiveness through an integrated
More news about: SK bioscience
Mar 18, 2026, 08:00 ET Millennial Shift Technologies Launches mShift Quantum AI™ Platform and AI Agents to Transform Commercial Insurance Operations
will be powered by intelligent infrastructure," said Mark Meury, Founder and CEO of Millennial Shift Technologies. "Quantum AI represents the next step in that evolution. AI that understands insurance workflows, processes submissions intelligently, and deploys agents that actively assist brokers
More news about: Millennial Shift Technologies, LLC
Mar 18, 2026, 08:00 ET TDH Holdings, Inc. Announces Receipt of Nasdaq Notice Regarding Board and Audit Committee Composition Requirements
compliance with Nasdaq Listing Rule 5605(b)(1) and Nasdaq Listing Rule 5605(c)(2)(A) by the earlier of the Company's next annual meeting of stockholders or March 11, 2027, or, if the next annual meeting of stockholders is held before September 8, 2026, then the Company must evidence compliance no later
More news about: TDH Holdings, Inc.
Mar 18, 2026, 08:00 ET AAPACN 2026 Conference Brings National Nursing Leaders Together to Strengthen the Future of Post-Acute Care
education in long-term and post-acute care. During the conference, AAPACN is raising funds to support future scholarships and continue investing in the next generation of post-acute care nursing leaders. AAPACN represents more than 18,000 nurses and leaders working in over 6,100 post-acute care facilities
More news about: American Association of Post-Acute Care Nursing
Mar 18, 2026, 08:00 ET Intec Bioplastics Launches $75 Million Regulation A+ Offering
across the United States. Capital raised will support the development of ten manufacturing and distribution centers across the United States over the next 48 months to expand production of Intec's EarthPlus® sustainable materials platform.
More news about: Intec Bioplastics, Inc.
Mar 18, 2026, 08:00 ET Empyrean Solutions Named Category Leader in All Six Chartis ALM 2025 Report Categories
scenario analysis, enhance forecasting accuracy, and reduce operational burden for finance and risk teams. The company continues to invest aggressively in next-generation architecture, high-performance‑ computation engines, and transparent analytic frameworks to ensure clients can respond quickly to changing
More news about: Empyrean Solutions
Mar 18, 2026, 08:00 ET Freenome Reports Data for Multiomic Blood-Based Screening Test for Lung Cancer
present the data at next month's AACR Annual Meeting in San Diego. Poster presentation details:Abstract Number: 1107Title: Development
More news about: Freenome Holdings, Inc.
Mar 18, 2026, 08:00 ET Cumulus Adds Connected Insulation Resistance Testing to Its AI and Bluetooth Platform, Beginning with Megger Integration
maintenance by replacing cumbersome paperwork with real time, worker-level data.," said Matthew Kleiman, CEO of Cumulus. "IR testing was the natural next step. Trusted tools are already in the hands of every electrician on these projects — what's been missing is a way to capture that work digitally, instantly,
More news about: Cumulus
Mar 18, 2026, 08:00 ET TrojAI Extends Enterprise AI Security with Agent-Led Red Teaming, Runtime Intelligence, and Coding Agent Protection
guardrails without disrupting developer productivity.With these three platform enhancements, TrojAI is redefining how enterprises protect the next generation of intelligent systems so they can confidently embrace AI innovation securely, transparently, and at scale.About TrojAITrojAI's
More news about: TrojAI
Mar 18, 2026, 08:00 ET Roborock F25 Ultra Named Winner in Better Homes & Gardens 2026 Clean House Awards
Award-Winning Deep Cleaning Power for Spring Cleaning SeasonAs households prepare for spring cleaning season, the F25 Ultra stands out as a next-generation solution built for the realities of today's homes where pets, kids, high-traffic areas, and mixed flooring demand more than surface-level
More news about: Roborock
Mar 18, 2026, 08:00 ET Small Ohio Company's Chemistry Breakthrough Could Have Major Defense Implications
contractors.Permanent magnet motors used in electric vehicles rely on rare earth elements to deliver the efficiency and performance required by next-generation EV platforms. At the same time, the rapid build-out of cloud and artificial intelligence infrastructure is driving demand for advanced cooling
More news about: OilPrice.com
Mar 18, 2026, 08:00 ET MetaVia Advances GLP-1-Based Obesity Program with IRB Approval for Higher-Dose Phase 1 Studies of DA-1726, a GLP-1 and Glucagon Dual Agonist Demonstrating Best-in-Class Potential for Weight Loss and Glucose Control
results will further de-risk the program and support advancement of DA-1726 into later-stage development, reinforcing its potential as a differentiated, next-generation GLP-1-based therapy that could offer meaningful advantages over existing options."About DA-1726
More news about: MetaVia Inc.
Mar 18, 2026, 07:58 ET Biotheryx Announces First Patient Dosed in the Dose Expansion Phase of BTX-9341-101 for the Treatment of HR+/HER2- Breast Cancer
safety, pharmacokinetics, and preliminary activity observed in the earlier dose escalation portion of the study support advancing BTX-9341 into this next stage of clinical evaluation. We believe the differentiated mechanism of targeted CDK4/6 degradation has the potential to address resistance seen with
More news about: Biotheryx, Inc.
Mar 18, 2026, 07:54 ET Inveniam hires Bain veteran Richard Walker as private markets shift toward autonomous capital
Richard Walker as Managing Director, Strategy and Market Development, as the firm accelerates the deployment of AI-native infrastructure to enable the next evolution of institutional finance: autonomous capital.
More news about: Inveniam Capital Partners, Inc.
Mar 18, 2026, 07:49 ET FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide
Medication Guide.If you miss a dose of ICOTYDE, take the dose as soon as you remember and go back to your regular schedule the next day.Please read the full
More news about: Johnson & Johnson
Mar 18, 2026, 07:45 ET New Oracle AI Smart Assistant Capabilities Help Restaurants Streamline Operations and Support
the benefits of Smart Assistant. The feature will be generally available for Simphony Cloud customers globally in more than 100 languages within the next 12 months.For more information, please visit
More news about: Oracle
Mar 18, 2026, 07:45 ET Fans Score with New Oracle Suite Service and Mobile Ordering Capabilities
operational agility.Oracle Restaurant Suites Management and Mobile Order and Pay will be available initially for customers in North America within the next 12 months. For more information, visit
More news about: Oracle
Mar 18, 2026, 07:44 ET Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026
Type: Poster Session: Experimental and Molecular Therapeutics: Next-Generation Targeted Therapies Directed Against Tumor Surface Antigens Date/Time:
More news about: Jazz Pharmaceuticals plc